Building Europe’s
Next-Gen Clinical Dev Platform
Bringing research options
to routine care
Building Europe’s
Every day of delay costs millions in sales — and leaves patients waiting for life-changing treatments.
Too many failing candidates enter late phases, blocking the pipeline for better drugs.
High costs limit the number of drugs a company can develop in parallel, hindering growth.
Pharma Value Proposition:
Avoid delays before they happen with real-time population insights — plan smarter and get studies started sooner.
Reduce screen failures: AI-guided pre-qualification ensures only eligible patients are referred.
Add patients equivalent to a high-performing trial site — without new infrastructure. Reach populations your sites could not access before, and ensure no patient is lost: our end-to-end process qualifies patients and coordinates their presentation at your site.
Activate existing and new referral networks to make it easier and more attractive to exchange the right patients, strengthening your study network.
"Given the Medical Research Act, we need to look beyond traditional site-only recruitment.
iduneo reaches new populations now and allows us to scale European-wide."
Patient Value Proposition
Patients and families are increasingly searching for clinical trial options. They know trials aren’t just a “last resort” and want to explore new therapies early.
Finding a study is just the start — most don’t know who to talk to, how to get tested, or where to get clear explanations.
Patients register and get a personal call-back to clarify questions and data requirements. Within 48 hours, they receive tailored study options. If interested, they are connected to a study center with full support for their first appointment — ensuring no time is lost and no patient is left alone.
OnkoPlus is active in Germany, Spain, and Italy — attracting patients from many other countries.
"Thank you for your dedicated support, whether I ultimately join the study or not.
It is great to know that you are here to help me."
Oncologists Value Proposition
OnkoPlus guides patients into studies without IT burden, fully GDPR compliant.
Join your regional network to gain visibility, contribute actively, and benefit from shared recruitment strength.
New approaches and incentive schemes ensure that trial participation fits smoothly into standard care.
OnkoPlus is active in Germany, Spain, and Italy — attracting patients from many other countries.
"Super, super, super.
This saves me so much time."
AI helps to extract information form unstructured documents as they are, and to understand how they relate to clinical trial documentation.
Oncology has been outside of the standard rule-based matching possibilities. With new approaches, more and more can be automated for medical review.
Driven by our extensive experience and passion for clinical research, we've tailored our approach to meet the needs of both our patients and industry partners.
Our team has over 40 years of combined expertise in clinical research, patient recruitment, trial site operations, and data analytics, gathered at leading pharmaceutical companies, renowned research institutions, and major clinical trial networks.
At iduneo, we merge AI-driven solutions with deep medical knowledge to bridge the gap between clinical research and patient care. We empower patients to access clinical trials as an additional treatment option while helping pharmaceutical companies accelerate the delivery of new therapies to market.
